I 
117TH CONGRESS 
1ST SESSION H. R. 2565 
To amend the Federal Food, Drug, and Cosmetic Act to allow manufacturers 
and sponsors of a drug to use alternative testing methods to animal 
testing to investigate the safety and effectiveness of a drug, and for 
other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 15, 2021 
Mr. BUCHANAN (for himself, Mrs. LURIA, Ms. MACE, Ms. SHERRILL, and Mr. 
BRENDAN F. BOYLE of Pennsylvania) introduced the following bill; which 
was referred to the Committee on Energy and Commerce 
A BILL 
To amend the Federal Food, Drug, and Cosmetic Act to 
allow manufacturers and sponsors of a drug to use alter-
native testing methods to animal testing to investigate 
the safety and effectiveness of a drug, and for other 
purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘FDA Modernization 
4
Act of 2021’’. 
5
VerDate Sep 11 2014 
21:58 May 28, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H2565.IH
H2565
pbinns on DSKJLVW7X2PROD with BILLS
2 
•HR 2565 IH
SEC. 2. ANIMAL TESTING ALTERNATIVES. 
1
Section 505 of the Federal Food, Drug, and Cosmetic 
2
Act (21 U.S.C. 355) is amended— 
3
(1) in subsection (b)(5)(B)(i)(II), by striking 
4
‘‘animal’’ and inserting ‘‘nonclinical tests or stud-
5
ies’’; 
6
(2) in subsection (i)— 
7
(A) in paragraph (1)(A), by striking ‘‘(in-
8
cluding tests on animals)’’; and 
9
(B) in paragraph (2)(B), by striking ‘‘ani-
10
mal or human studies’’ and inserting ‘‘nonclin-
11
ical tests or studies’’; and 
12
(3) after subsection (y), by inserting the fol-
13
lowing: 
14
‘‘(z) NONCLINICAL TEST OR STUDY DEFINED.—For 
15
purposes of this section, the term ‘nonclinical test or 
16
study’ means a test or study that is most likely to predict 
17
human response based on scientific evidence and occurs 
18
before or during the clinical trial phase of the investigation 
19
of the safety and effectiveness of a drug. Such test or 
20
study may include the following: 
21
‘‘(1) Cell-based assays. 
22
‘‘(2) Organ chips and microphysiological sys-
23
tems. 
24
‘‘(3) Sophisticated computer modeling. 
25
‘‘(4) Other human biology-based test methods. 
26
VerDate Sep 11 2014 
21:58 May 28, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H2565.IH
H2565
pbinns on DSKJLVW7X2PROD with BILLS
3 
•HR 2565 IH
‘‘(5) Animal tests.’’. 
1
Æ 
VerDate Sep 11 2014 
21:58 May 28, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H2565.IH
H2565
pbinns on DSKJLVW7X2PROD with BILLS
